Abstract:OBJECTIVE:Spinal muscular atrophy (SMA) is an autosomal recessive disorder that results in symmetrical muscle weakness and wasting due to degeneration of the anterior horns of the spinal cord. The clinical picture of SMA is variable and childhood SMA has been classified into 3 types on the basis of the age of onset and clinical course. The survival motor neuron (SMN) gene was mapped to chromosome 5q13. The SMN1 gene has been recognized to be responsible for SMA because of homozygous deletions or intragenic mutations in SMN1 results in childhood onset of SMA. The main objective of this study was to determine the deletion frequency of SMN1 gene and to apply gene analysis in children patients with SMA. METHODS:The SMA patients were diagnosed and clinically typed according to the international diagnostic criteria, following up cases, and gene analysis. The PCR enzyme assay was used to detect the homozygous deletion of SMN1 gene in SMA patients. A dosage assay that combined multiplexed allele-specific PCR and DHPLC was used to determine the copy numbers of the SMN1 and SMN2 and detect SMN1 heterozygous deletion. RESULTS:(1) A total of 267 patients with SMA were diagnosed from 338 suspicious cases and 143, 82, and 42 cases were typed as types I, II, and III, with the percentages of 53.6% (143/267), 30.7% (82/267) and 15.7% (42/267), respectively. (2) Results of the present study showed that 68.5% (183/267) of SMA patients had homozygous deletions of exons 7 and 8 of SMN1 gene and 12.7% (34/267) had homozygous deletions of only exon 7 of SMN1 gene. The SMN1 heterozygous deletion was confirmed in 12.4% (33/267) of SMA patients. Non-deletion SMA patients accounted for 6.4%(17/267). The homozygous deletions of only exon 8 of SMN1 gene could not be detected. (3) The rates of homozygous or heterozygous deletion in types I and II were very similar. The rate of homozygous deletion was lower in type III than that in type I or II and rate of heterozygous deletion of type III was higher than that in types I or II. CONCLUSION:(1) The frequency and pattern of deletions in the Chinese children patients with SMA are significantly different from that observed in Caucasians populations. Further gene characterization and subtle mutations within the SMN1 gene need to be studied in order to define the molecular basis of SMA in the Chinese population. (2) The gene diagnosis is a special and non invasive method as compared with other methods. A total of 80% patients can be diagnosed through the analysis of the homozygous deletion of SMN1 gene. (3) The clinical diagnosis and gene detection need to be studied in future for the SMA patients with type III.

[Analysis of 4 children with DYNC1H1 gene related spinal muscular atrophy with lower extremity predominant 1].

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Muscle and Bone Characteristics of a Chinese Family with Spinal Muscular Atrophy, Lower Extremity Predominant 1 (SMALED1) Caused by a Novel Missense DYNC1H1 Mutation

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations

[Clinical characteristics and genetics functional analysis of two children with Spinal muscular atrophy]

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

[Molecular analysis of survival motor neuron gene in 338 suspicious children patients with spinal muscular atrophy].

Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

ASAH1 gene mutation causing spinal muscular atrophy with progressive myoclonic epilepsy in a Chinese child and literature review

Exome Sequencing Identifies De Novo DYNC1H1 Mutations Associated with Distal Spinal Muscular Atrophy and Malformations of Cortical Development

Discovery of specific mutations in spinal muscular atrophy patients by next-generation sequencing

Copy Number Variation of SMN1 and SMN2 Genes in Spinal Muscular Atrophy and Analysis of Its Clinical Significance

Nutritional, Lipid Metabolic and Body Composition Features of Children with Spinal Muscular Atrophy

[Analysis of a child with congenital muscular dystrophy due to a novel variant of the LMNA gene]

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Delayed Diagnosis of Spinal Muscular Atrophy in Two Chinese Families due to Novel SMN1 Deletions

Adult-onset SMALED2 Due to a Novel BICD2 Mutation Presenting with Asymmetrical Lower Limb Involvement

[Mutation Analysis of SMN1 Gene in Patients with Spinal Muscular Atrophy].

Compound heterozygous DYSF variants causing limb‐girdle muscular dystrophy type 2B in a Chinese family